Why VLA and not BNO???, page-15

Yes, lots of speculation around the stock but IMO its not worth trying to match the VLA deal to what might happen with BNO (as mentioned in my earlier post). However, I know punters will do that.

As for who is selling (and buying) I don't have any idea about that. I don't have access to that information but I am happy to see that there are ready buyers around to soak up the selling. I doubt that Merck would be active in any meaningful way at all - I reckon they are happy to maintain a 4.5% shareholding and keep it there - while they are involved in trials with BNO. Merck will have worked out what the potential value of the drugs under development are and they are most likely to base future decisions on that evaluation. GLTA